癌の進行を調節する物質:サクシニレーション
1Institute of Biochemistry, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Cancers
|August 28, 2025
まとめ
タンパク質の改変であるライシンサキニレーションは,がんの進行とますます関連しています. このプロセスを理解し 標的となる薬を開発することで 様々な癌の治療戦略が生まれます
科学分野:
- 生物化学
- 腫瘍学
- 分子生物学
背景:
- リシンサキニレーションは,最近発見された翻訳後のタンパク質の改変である.
- アセチル化とリン酸化のようなタンパク質の伝統後の改変 (PTM) は,癌と関連していることが知られている.
- 肺癌,前立腺癌,腎臓癌の発生におけるサクシニレーションとデサクシニレーションの重要な役割を新鮮に示しています.
研究 の 目的:
- 常見がんにおけるタンパク質サキニレーションに関する現在の研究をレビューする.
- スキニレーションを標的とする薬の開発について議論する
- 分子メカニズムと治療目標の洞察を提供するためです
主な方法:
- 癌におけるタンパク質サキニレーションに関する包括的な文献レビュー.
- サキニレーションによる癌の進行を調節する分子機構の分析
- 癌に関連したタンパク質における主要なサクシニレーション部位の特定
主要な成果:
- タンパク質サキニレーションは,特にヒストン以外のタンパク質において,癌の発生に大きく影響する.
- サクシニロームのプロファイリングは,様々な癌の重要な規制作用を明らかにしています.
- サクシニレーション経路を標的とする薬の特定と開発に進展がみられた.
結論:
- タンパク質のサキニレーションは 癌の進行における重要な要因です
- サクシニレーション経路をターゲットにすることで 新しいがん治療法への希望が生まれます
- 癌の治療を進めるためには,サキニル化タンパク質と標的薬のさらなる研究が不可欠です.
さらに関連する動画
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Covalently Linked Protein Regulators
7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.1K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K


